<DOC>
	<DOCNO>NCT00969631</DOCNO>
	<brief_summary>The purpose study compare determine efficacy combine metformin Clomiphene citrate administration laparoscopic ovarian diathermy ( LOD ) infertile woman Polycystic ovary syndrome ( PCOS ) respond treatment Clomiphene alone .</brief_summary>
	<brief_title>Combined Metformin Clomiphene Citrate ( CC ) Laparoscopic Ovarian Diathermy Women With CC Resistant Polycystic Ovary Syndrome ( PCOS )</brief_title>
	<detailed_description>All patient combine metformin-CC group receive metformin HCl ( Cidophage® ; Chemical Industries Development , Cairo , Egypt ) , 500 mg thrice daily 6-8 week . Then end period , receive 100 mg CC ( Clomid® ; Global Napi Pharmaceuticals , Cairo , Egypt ) 5 day start day 3 menstruation ( increase 50 mg next cycle case anovulation ) . Patients continue treatment six cycle . Metformin stop pregnancy document . All patient control group underwent laparoscopic ovarian diathermy , follow 6 month .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Enclomiphene</mesh_term>
	<mesh_term>Zuclomiphene</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>CC resistant PCOS Congenital adrenal hyperplasia Cushing syndrome Androgen secreting tumor</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>36 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Polycystic ovary syndrome</keyword>
	<keyword>clomiphene resistance</keyword>
	<keyword>metformin</keyword>
	<keyword>laparoscopic ovarian diathermy</keyword>
</DOC>